166 related articles for article (PubMed ID: 37816055)
1. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma.
Liu B; Zhang B; Qi J; Zhou H; Tan L; Huang J; Huang J; Fang X; Gong L; Luo J; Liu S; Fu L; Ling F; Ma S; Lai-Wan Kwong D; Wang X; Guan XY
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307914120. PubMed ID: 37816055
[TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma.
Chen C; Yang C; Tian X; Liang Y; Wang S; Wang X; Shou Y; Li H; Xiao Q; Shu J; Sun M; Chen K
Cancer Med; 2023 Jul; 12(13):14468-14483. PubMed ID: 37184125
[TBL] [Abstract][Full Text] [Related]
5. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
Li W; Xu T; Jin H; Li M; Jia Q
Pathol Res Pract; 2024 Jan; 253():155002. PubMed ID: 38056131
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma.
Dunbar KJ; Karakasheva TA; Tang Q; Efe G; Lin EW; Harris M; Sahu V; Sachdeva UM; Hu J; Klein-Szanto AJ; Henick B; Diehl JA; Nakagawa H; Rustgi AK
Mol Cancer Res; 2023 Jul; 21(7):741-752. PubMed ID: 37027010
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma.
Qiu L; Yue J; Ding L; Yin Z; Zhang K; Zhang H
Cancer Lett; 2022 Oct; 546():215860. PubMed ID: 35948121
[TBL] [Abstract][Full Text] [Related]
11. Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer associated fibroblasts.
Li J; Gu X; Wan G; Wang Y; Chen K; Chen Q; Lu C
J Transl Med; 2023 Apr; 21(1):248. PubMed ID: 37029408
[TBL] [Abstract][Full Text] [Related]
12. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma.
Zhao G; Li H; Guo Q; Zhou A; Wang X; Li P; Zhang S
Cancer Med; 2020 Apr; 9(7):2500-2513. PubMed ID: 32030915
[TBL] [Abstract][Full Text] [Related]
13. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
Shi Z; Jiang T; Cao B; Sun X; Liu J
Exp Cell Res; 2022 Mar; 412(2):113033. PubMed ID: 35041823
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
Liang W; Wang C; Wang J; Zhang M
Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
[TBL] [Abstract][Full Text] [Related]
17. PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
[TBL] [Abstract][Full Text] [Related]
19. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
20. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
Zhou Z; Zhou Q; Wu X; Xu S; Hu X; Tao X; Li B; Peng J; Li D; Shen L; Cao Y; Yang L
Cancer Lett; 2020 Mar; 473():62-73. PubMed ID: 31904479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
